Back
First Trust Nasdaq Pharmaceuticals ETF Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
27.74
Seasonality Move:
3.41%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...First Trust Nasdaq Pharmaceuticals ETF Price Quote
$27.74
-0.04 (1.31%)
(Updated: November 22, 2024 at 5:26 AM ET)
First Trust Nasdaq Pharmaceuticals ETF Key Stats
Sell
37
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Day range:
$27.41 - $27.82
52-week range:
$24.37 - $29.72
Dividend yield:
1.59%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
7.7K
Avg. volume:
2.8K
1-year change:
13.49%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does First Trust Nasdaq Pharmaceuticals ETF Make?
Data Unavailable
Is First Trust Nasdaq Pharmaceuticals ETF Growing As A Company?
Data Unavailable
First Trust Nasdaq Pharmaceuticals ETF Stock Price Performance
-
Did First Trust Nasdaq Pharmaceuticals ETF Stock Go Up Last Month?
First Trust Nasdaq Pharmaceuticals ETF share price went down by -2.41% last month -
Did FTXH's Share Price Rise Over The Last Year?
FTXH share price rose by 13.49% over the past 1 year
What Is First Trust Nasdaq Pharmaceuticals ETF 52-Week High & Low?
-
What Is First Trust Nasdaq Pharmaceuticals ETF’s 52-Week High Share Price?
First Trust Nasdaq Pharmaceuticals ETF has traded as high as $29.72 over the past 52 weeks -
What Is First Trust Nasdaq Pharmaceuticals ETF’s 52-Week Low Share Price?
First Trust Nasdaq Pharmaceuticals ETF has traded as low as $24.37 over the past 52 weeks
First Trust Nasdaq Pharmaceuticals ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy First Trust Nasdaq Pharmaceuticals ETF?
Data Unavailable
Is First Trust Nasdaq Pharmaceuticals ETF Cash Flow Positive?
Data Unavailable
First Trust Nasdaq Pharmaceuticals ETF Return On Invested Capital
Data Unavailable
First Trust Nasdaq Pharmaceuticals ETF Earnings Date & Stock Price
-
What Is First Trust Nasdaq Pharmaceuticals ETF's Stock Price Today?
A single share of FTXH can be purchased today for 27.78 -
What Is First Trust Nasdaq Pharmaceuticals ETF’s Stock Symbol?
First Trust Nasdaq Pharmaceuticals ETF trades on the nasdaq under the ticker symbol: FTXH -
When Is First Trust Nasdaq Pharmaceuticals ETF’s Next Earnings Date?
The next quarterly earnings date for First Trust Nasdaq Pharmaceuticals ETF is scheduled on November 22, 2024 -
When Is FTXH's next ex-dividend date?
First Trust Nasdaq Pharmaceuticals ETF's next ex-dividend date is September 26, 2024 -
How To Buy First Trust Nasdaq Pharmaceuticals ETF Stock?
You can buy First Trust Nasdaq Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
First Trust Nasdaq Pharmaceuticals ETF Competitors
-
Who Are First Trust Nasdaq Pharmaceuticals ETF's Competitors?
Below is a list of companies who compete with First Trust Nasdaq Pharmaceuticals ETF or are related in some way:
First Trust Nasdaq Pharmaceuticals ETF Dividend Yield
-
What Is FTXH Dividend Yield?
First Trust Nasdaq Pharmaceuticals ETF’s dividend yield currently is 1.59% -
What Is First Trust Nasdaq Pharmaceuticals ETF’s Payout Ratio?
First Trust Nasdaq Pharmaceuticals ETF’s payout ratio is 0% -
When Did First Trust Nasdaq Pharmaceuticals ETF Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is First Trust Nasdaq Pharmaceuticals ETF’s Dividend Per Share?
First Trust Nasdaq Pharmaceuticals ETF pays a dividend of $0.00 per share
First Trust Nasdaq Pharmaceuticals ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable